SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001554795-21-000150
Filing Date
2021-04-29
Accepted
2021-04-29 16:49:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 1) osmt0429sch13ga.htm SC 13G/A 32033
  Complete submission text file 0001554795-21-000150.txt   33568
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Subject) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-90830 | Film No.: 21871566
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 212-593-6900
Orbit Co-Invest I LLC (Filed by) CIK: 0001751055 (see all company filings)

IRS No.: 811293728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A